Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Rui Campante Teles, Eric Van Belle, Radoslaw Parma, Giuseppe Tarantini, Nicolas van Mieghem, Darren Mylotte, Joana Delgado Silva, Stephen O'Connor, Lars Sondegaard, Andre Luz, Ignacio Jesus Amat-Santos, Dabit Arzamendi, Daniel Blackman, Ole De Backer, Vijay Kunadian, Gill Louise Buchanan, Phil MacCarthy, Philipp Lurz, Christopher Naber, Alaide Chieffo, Valeria Paradies, Martine Gilard, Flavien Vincent, Chiara Fraccaro, Julinda Mehilli, Cristina Giannini, Bruno Silva, Petra Poliacikova, Nicole Karam, Verena Veulemans, Holger Thiele, Thomas Pilgrim, Marleen van Wely, Stefan James, Michael Rahbek Schmidt, Anselm Uebing, Andreas Rück, Alexander Ghanem, Ziyad Ghazzal, Francis R Joshi, Luca Favero, Renicus Hermanides, Vlasis Ninios, Luca Nai Fovino, Rutger-Jan Nuis, Pierre Deharo, Petr Kala, Gabby Elbaz-Greener, Didier Tchétché, Eustachio Agricola, Matthias Thielmann, Erwan Donal, Nikolaos Bonaros, Steven Droogmans, Martin Czerny, Andreas Baumbach, Emanuele Barbato, Dariusz Dudek
The percutaneous treatment of structural, valvular, and non-valvular heart disease (SHD) is rapidly evolving. The Core Curriculum (CC) proposed by the EAPCI describes the knowledge, skills, and attitudes that define competency levels required by newly trained SHD interventional cardiologists (IC) and provides guidance for training centres. SHD ICs are cardiologists who have received complete interventional cardiology training. They are multidisciplinary team specialists who manage adult SHD patients from diagnosis to follow-up and perform percutaneous procedures in this area...
August 30, 2024: EuroIntervention
#2
JOURNAL ARTICLE
Michael Joner, Alicia Beele
No abstract text is available yet for this article.
September 2, 2024: EuroIntervention
#3
JOURNAL ARTICLE
Tom Adriaenssens, Peter Sinnaeve
No abstract text is available yet for this article.
September 2, 2024: EuroIntervention
#4
JOURNAL ARTICLE
Victoria Delgado, Elena Díaz Peláez
No abstract text is available yet for this article.
September 2, 2024: EuroIntervention
#5
RANDOMIZED CONTROLLED TRIAL
Hiromasa Otake, Takashi Kubo, Kiyoshi Hibi, Makoto Natsumeda, Masaru Ishida, Toru Kataoka, Tomofumi Takaya, Masamichi Iwasaki, Shinjo Sonoda, Toshiro Shinke, Gaku Nakazawa, Yu Takahashi, Tetsuya Ioji, Takashi Akasaka, Opinion Acs Investigators
BACKGROUND: The clinical benefits of optical frequency domain imaging (OFDI)-guided percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) remain unclear. AIMS: We sought to compare intravascular ultrasound (IVUS)- and OFDI-guided PCI in patients with ACS. METHODS: OPINION ACS is a multicentre, prospective, randomised, non-inferiority trial that compared OFDI-guided PCI with IVUS-guided PCI using current-generation drug-eluting stents in ACS patients (n=158)...
September 2, 2024: EuroIntervention
#6
JOURNAL ARTICLE
Benjamin Bay, Alina Goßling, Marko Remmel, Peter M Becher, Benedikt Schrage, David L Rimmele, Götz Thomalla, Stefan Blankenberg, Peter Clemmensen, Fabian J Brunner, Christoph Waldeyer
BACKGROUND: Acute ischaemic stroke (AIS) after percutaneous coronary intervention (PCI) is a rare, but debilitating, complication. However, contemporary data from real-world unselected patients are scarce. AIMS: We aimed to explore the temporal trends, outcomes and variables associated with AIS as well as in-hospital all-cause mortality in a nationwide cohort. METHODS: A retrospective analysis of healthcare records from 2006-2021 was implemented...
September 2, 2024: EuroIntervention
#7
JOURNAL ARTICLE
Robin Le Ruz, Lionel Leroux, Thibault Lhermusier, Thomas Cuisset, Eric Van Belle, Alain Dibie, Vincenzo Palermo, Didier Champagnac, Jean-François Obadia, Emmanuel Teiger, Patrick Ohlman, Didier Tchétché, Hervé Le Breton, Christophe Saint-Etienne, Pierre-Guillaume Piriou, Julien Plessis, Sylvain Beurtheret, Florence Du Chayla, Manon Leclère, Thierry Lefèvre, Jean-Philippe Collet, Hélène Eltchaninoff, Martine Gilard, Bernard Iung, Thibaut Manigold, Vincent Letocart, On Behalf Of Stop-As And France-Tavi Investigators
BACKGROUND: Large datasets of transcatheter aortic valve implantation (TAVI) for pure aortic valve regurgitation (PAVR) are scarce. AIMS: We aimed to report procedural safety and long-term clinical events (CE) in a contemporary cohort of PAVR patients treated with new-generation devices (NGD). METHODS: Patients with grade III/IV PAVR enrolled in the FRANCE-TAVI Registry were selected. The primary safety endpoint was technical success (TS) according to Valve Academic Research Consortium 3 criteria...
September 2, 2024: EuroIntervention
#8
JOURNAL ARTICLE
Mert Tokcan, Jan Federspiel, Lucas Lauder, Mathias Hohl, Hussam Al Ghorani, Saarraaken Kulenthiran, Stephanie Bettink, Michael Böhm, Bruno Scheller, Thomas Tschernig, Felix Mahfoud
BACKGROUND: A detailed understanding of the sympathetic innervation of coronary arteries is relevant to facilitate the development of novel treatment approaches. AIMS: This study aimed to quantitatively examine periarterial innervation in human epicardial coronary arteries. METHODS: Coronary arteries with adjacent epicardial adipose tissue were excised along the left main coronary artery (LMCA), left anterior descending artery (LAD), left circumflex artery (LCx), and right coronary artery (RCA) from 28 body donors and examined histologically...
September 2, 2024: EuroIntervention
#9
JOURNAL ARTICLE
Michael Haude, Juan F Iglesias, Hector M Garcia-Garcia, Dimitrios Barlagiannis, Sophie Degrauwe, Gebremedhin Melaku, Solomon Beyene, Ron Waksman
No abstract text is available yet for this article.
September 2, 2024: EuroIntervention
#10
JOURNAL ARTICLE
Thomas Engstrøm, Jasmine Melissa Madsen, Holger Thiele, Uwe Zeymer
No abstract text is available yet for this article.
September 2, 2024: EuroIntervention
#11
REVIEW
Andreas Baumbach, Kush P Patel, Tanja K Rudolph, Victoria Delgado, Hendrik Treede, Alexander R Tamm
Aortic regurgitation (AR) is a common clinical disease associated with significant morbidity and mortality. Investigations based largely on non-invasive imaging are pivotal in discerning the severity of disease and its impact on the heart. Advances in technology have contributed to improved risk stratification and to our understanding of the pathophysiology of AR. Surgical aortic valve replacement is the predominant treatment. However, its use is limited to patients with an acceptable surgical risk profile...
September 2, 2024: EuroIntervention
#12
LETTER
Thomas Engstrøm, Jasmine Melissa Madsen
No abstract text is available yet for this article.
August 19, 2024: EuroIntervention
#13
EDITORIAL
Sameer Gafoor, Sidakpal Panaich
No abstract text is available yet for this article.
August 19, 2024: EuroIntervention
#14
LETTER
David Hildick-Smith, Sandeep Arunothayaraj
No abstract text is available yet for this article.
August 19, 2024: EuroIntervention
#15
JOURNAL ARTICLE
Tatjana Potpara
No abstract text is available yet for this article.
August 19, 2024: EuroIntervention
#16
LETTER
David Del Val, Fernando Alfonso, Elvin Kedhi, On Behalf Of The Combine Oct-Ffr Trial Investigators
No abstract text is available yet for this article.
August 19, 2024: EuroIntervention
#17
LETTER
Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantinos Tsioufis
No abstract text is available yet for this article.
August 19, 2024: EuroIntervention
#18
JOURNAL ARTICLE
Andrea Milzi, Tobias Álvaro Thomsen, Antonio Landi, Rosalia Dettori, Nikolaus Marx, Florian Kahles, Javier Escaned, Hernán Mejía-Rentería, Mathias Burgmaier, Marco Valgimigli
No abstract text is available yet for this article.
August 19, 2024: EuroIntervention
#19
MULTICENTER STUDY
Willem Lambertus Wilbert Bor, Jaouad Azzahhafi, Nino di Maio, Niels M R van der Sangen, Ashley Verburg, Senna Rayhi, Joyce Peper, Dean R P P Chan Pin Yin, Jurrien M Ten Berg
BACKGROUND: Acute coronary syndrome (ACS) is frequently accompanied by newly diagnosed atrial fibrillation (AF). AIMS: We aimed to compare the risk of major adverse cardiovascular events (MACE) in ACS patients presenting with known, newly diagnosed, or no AF. METHODS: In our multicentre, prospective registry study, we included patients with confirmed ACS. Patients are classified as having known, newly diagnosed or no AF. Newly diagnosed AF is subdivided according to the duration of the episode, time of onset, post-coronary artery bypass graft (CABG) or spontaneous occurrence, and treatment with oral anticoagulants (OAC)...
August 19, 2024: EuroIntervention
#20
JOURNAL ARTICLE
Ali Husain, Julius Jelisejevas, John King Khoo, Mariama Akodad, Andrew Chatfield, Fady Zaky, Stephanie L Sellers, Jonathon A Leipsic, Philipp Blanke, David A Wood, David Meier, Janarthanan Sathananthan, John G Webb
No abstract text is available yet for this article.
August 19, 2024: EuroIntervention
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
